Holen Sie sich die Stockscreener-App
69.55
0.89%
0.555
Schlusskurs vom Vortag:
$68.99
Offen:
$69.24
24-Stunden-Volumen:
519.53K
Relative Volume:
0.37
Marktkapitalisierung:
$7.92B
Einnahmen:
$13.18B
Nettoeinkommen (Verlust:
$419.00M
KGV:
21.26
EPS:
3.2704
Netto-Cashflow:
$521.00M
1W Leistung:
-6.41%
1M Leistung:
-7.61%
6M Leistung:
-4.44%
1J Leistung:
-1.23%
1-Tages-Spanne:
$68.95
$69.93
1-Wochen-Bereich:
$68.70
$76.03
52-Wochen-Spanne:
$61.95
$89.29
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
69.50 | 7.86B | 13.18B | 419.00M | 521.00M | 3.2704 |
MCK
Mckesson Corp
|
729.90 | 87.17B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
261.18 | 50.53B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
183.37 | 42.74B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
2.00 | 1.81B | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-16 | Eingeleitet | BTIG Research | Neutral |
| 2026-04-15 | Eingeleitet | Citigroup | Buy |
| 2026-02-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein : 2026 Proxy Supplement May 12, 2026 of 2025 - marketscreener.com
Right to Read, but Wrong to Write - Health API Guy
5 Must-Read Analyst Questions From Henry Schein’s Q1 Earnings Call - The Globe and Mail
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein stock (US42548G1040): Dental and medical distributor reports Q1 results and raises outl - AD HOC NEWS
Henry Schein stock (US42548G1040): Q1 2026 results and buyback drive sentiment - AD HOC NEWS
Barclays Maintains Henry Schein(HSIC.US) With Buy Rating, Maintains Target Price $86 - Moomoo
Henry Schein tops expectations, but shares dip slightly after results - MSN
Henry Schein Inc stock (US8064071025): Dental and medical distributor reports Q1 results and raises - AD HOC NEWS
Henry Schein, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - 富途牛牛
Henry Schein, Inc. Just Recorded A 8.1% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
Earnings Beat: Henry Schein, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Henry Schein Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Analysts Are Bullish on Top Healthcare Stocks: Henry Schein (HSIC), Alphatec Holdings (ATEC) - The Globe and Mail
Number of shareholders of Henry Schein, Inc. – MIL:1HSIC - TradingView
Henry Schein Earnings Call Highlights Margin Momentum - The Globe and Mail
Henry Schein’s THRIVELIVE 2026 Delivers on Innovation, Education, and Inspiration - Dentistry Today
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Research Alert: CFRA Maintains Hold Rating On Shares Of Henry Schein - Moomoo
Henry Schein Still Sees 2026 Adjusted Ebitda Up Mid-Single Digits >HSIC - Moomoo
Here's why Henry Schein (HSIC) is a strong value stock - MSN
Transcript: Henry Schein Q1 2026 Earnings Conference Call - Sahm
UBS Adjusts Price Target on Henry Schein to $85 From $87, Maintains Neutral Rating - marketscreener.com
Here's Why Henry Schein (HSIC) is a Strong Value Stock - Yahoo Finance
Henry Schein, Inc. (NASDAQ:HSIC) Q1 2026 Earnings Call Transcript - Insider Monkey
HSIC Q1 Deep Dive: Dental and Technology Strength Offset Medical Softness, Value Initiatives Underway - The Globe and Mail
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein Q1 Earnings Call Highlights - Yahoo Finance
Henry Schein (HSIC) Q1 2026 Earnings Call Transcript - Fortune
Piper Sandler Cuts Price Target on Henry Schein to $91 From $99 - marketscreener.com
Jefferies Adjusts Price Target on Henry Schein to $80 From $89, Maintains Hold Rating - marketscreener.com
Henry Schein (Nasdaq: HSIC) reports Q1 2026 net sales of $3,368M - Stock Titan
Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 2018. - marketscreener.com
Henry Schein Q1 2026 Earnings Call Transcript - MarketBeat
Henry Schein, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Henry Schein (HSIC) Q1 2026 Earnings Transcript - AOL.com
Henry Schein Fiscal Q1 Non-GAAP Earnings, Net Sales Rise; Reaffirms 2026 Outlook - Moomoo
Research Alert: Henry Schein: U.s. Dental Sales Growth Supports Q1 Eps Beat - Moomoo
Earnings call transcript: Henry Schein Q1 2026 beats expectations, stock dips - Investing.com
Compared to Estimates, Henry Schein (HSIC) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
HSIC Q1 Earnings & Revenues Surpass Estimates, Gross Margin Rises - TradingView
Henry Schein, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:HSIC) 2026-05-05 - Seeking Alpha
Q1 2026 Henry Schein Inc Earnings Call Transcript - GuruFocus
Henry Schein, Inc. Reports Earnings Results for the First Quarter Ended March 28, 2026 - marketscreener.com
Henry Schein : Q1 2026 Earnings Conference Call - marketscreener.com
Henry Schein reaffirms annual profit forecast, beats Q1 estimates on dental strength - marketscreener.com
Henry Schein Inc (NASDAQ:HSIC) Surges After Q1 Earnings Beat - ChartMill
Henry Schein : First Quarter 2026 Financial Presentation - marketscreener.com
Henry Schein beats estimates but stock edges down - Investing.com India
Henry Schein beats estimates but stock edges down By Investing.com - Investing.com Nigeria
Henry Schein (HSIC) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
24.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):